Sun Pharma recalls eye drops in India after contamination scare

Sun Pharma has initiated a recall of its eye drops in the Indian market following concerns regarding potential product contamination. The pharmaceutical company is taking this action to address safety risks associated with the affected batches.

This recall highlights ongoing quality control challenges within the pharmaceutical sector. Regulatory authorities are expected to monitor the situation to ensure patient safety and adherence to manufacturing standards as the company works to mitigate the impact of the contamination scare.